-
Je něco špatně v tomto záznamu ?
Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy
M Beranek, P Kolar, S Tschoplova, K Kankova, A Vasku
Jazyk angličtina Země Irsko
- MeSH
- diabetická retinopatie genetika krev MeSH
- fibroblastový růstový faktor 2 genetika krev MeSH
- financování organizované MeSH
- frekvence genu MeSH
- genetická variace MeSH
- genotyp MeSH
- jednonukleotidový polymorfismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- patologická angiogeneze genetika MeSH
- polymerázová řetězová reakce MeSH
- polymorfismus konformace jednovláknové DNA MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
The basic fibroblast growth factor (bFGF) is considered to be one of the candidate genes in the processes of tumour growth and angiogenesis. The aim of the present investigation was to find possible association of new polymorphisms in bFGF with proliferative diabetic retinopathy (PDR) and determine the plasma level in PDR. Allele, genotype and haplotype frequencies were determined in the association study comprising three groups of Caucasian subjects (n=488) (diabetics with/ PDR/ and without retinopathy/ non-PDR/ and non-diabetics/ non-DM/) in order to identify genetic marker for PDR. The plasma level of the bFGF protein was analysed by ELISA method. Significantly higher frequencies of 754C allele of the new 754C/G polymorphisms was found between PDR and non-DM group (p=0.05, OR=1.38). The comparison of plasma level of the bFGF showed statistically significant difference among studied groups (p=0.001). The bFGF plasma level in PDR group was significantly higher than in the groups of non-PDR and non-DM (p=0.017, p=0.001, respectively) and was significantly higher for CC and GC genotypes of 754C/G polymorphism in PDR group (p=0.006). Increased plasma level of the bFGF confirmed the importance of this candidate gene in the formation of PDR. However, the regulatory mechanisms of the bFGF level need further examinations.
Citace poskytuje Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026797
- 003
- CZ-PrNML
- 005
- 20111210192456.0
- 008
- 101019s2008 ie e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.diabres.2007.09.012 $2 doi
- 035 __
- $a (PubMed)17997184
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Beránek, Michal. $7 xx0193695
- 245 10
- $a Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy / $c M Beranek, P Kolar, S Tschoplova, K Kankova, A Vasku
- 314 __
- $a Faculty of Medicine, Department of Pathophysiology, Masaryk University Brno, Czech Republic. mberanek@med.muni.cz
- 520 9_
- $a The basic fibroblast growth factor (bFGF) is considered to be one of the candidate genes in the processes of tumour growth and angiogenesis. The aim of the present investigation was to find possible association of new polymorphisms in bFGF with proliferative diabetic retinopathy (PDR) and determine the plasma level in PDR. Allele, genotype and haplotype frequencies were determined in the association study comprising three groups of Caucasian subjects (n=488) (diabetics with/ PDR/ and without retinopathy/ non-PDR/ and non-diabetics/ non-DM/) in order to identify genetic marker for PDR. The plasma level of the bFGF protein was analysed by ELISA method. Significantly higher frequencies of 754C allele of the new 754C/G polymorphisms was found between PDR and non-DM group (p=0.05, OR=1.38). The comparison of plasma level of the bFGF showed statistically significant difference among studied groups (p=0.001). The bFGF plasma level in PDR group was significantly higher than in the groups of non-PDR and non-DM (p=0.017, p=0.001, respectively) and was significantly higher for CC and GC genotypes of 754C/G polymorphism in PDR group (p=0.006). Increased plasma level of the bFGF confirmed the importance of this candidate gene in the formation of PDR. However, the regulatory mechanisms of the bFGF level need further examinations.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a diabetická retinopatie $x genetika $x krev $7 D003930
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblastový růstový faktor 2 $x genetika $x krev $7 D016222
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetická variace $7 D014644
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a patologická angiogeneze $x genetika $7 D009389
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a polymorfismus konformace jednovláknové DNA $7 D018807
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Kolář, Petr, $d 1970- $7 xx0037722
- 700 1_
- $a Tschöplová, Svatava. $7 _AN033174
- 700 1_
- $a Kaňková, Kateřina, $d 1971- $7 mzk2003190820
- 700 1_
- $a Vašků, Anna, $d 1954- $7 mzk2006356130
- 773 0_
- $w MED00001385 $t Diabetes research and clinical practice $g Roč. 79, č. 2 (2008), s. 362-367 $x 0168-8227
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101102114518 $b ABA008
- 991 __
- $a 20101102133157 $b ABA008
- 999 __
- $a ok $b bmc $g 801902 $s 666662
- BAS __
- $a 3
- BMC __
- $a 2008 $b 79 $c 2 $d 362-367 $m Diabetes research and clinical practice $n Diabetes Res Clin Pract $x MED00001385
- LZP __
- $a 2010-B3/vtme